Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 14, 2017; 23(42): 7551-7562
Published online Nov 14, 2017. doi: 10.3748/wjg.v23.i42.7551
Published online Nov 14, 2017. doi: 10.3748/wjg.v23.i42.7551
Figure 1 Experimental treatment scheme.
Group A: 90Y-ITGA6B4 + BEZ235; Group B: 90Y-ITGA6B4; Group C: BEZ235; Group D: Vehicle.
- Citation: Aung W, Tsuji AB, Sudo H, Sugyo A, Ukai Y, Kouda K, Kurosawa Y, Furukawa T, Saga T, Higashi T. Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor. World J Gastroenterol 2017; 23(42): 7551-7562
- URL: https://www.wjgnet.com/1007-9327/full/v23/i42/7551.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i42.7551